K. Amato

发表

Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1 expression and phosphorylation.

Andrew K Hastings, John V. Williams, L. S. Peterson, 2016, Virology.

Targeting the EPHA2 receptor tyrosine kinase in KRAS and EGFR mutant lung cancer

K. Amato, 2015 .

Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer Modeling

N. Socci, A. Viale, M. Ladanyi, 2011, Science Translational Medicine.

EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer.

W. Pao, N. Gray, D. Colvin, 2016, Cancer research.

EPHA2BlockadeOvercomesAcquired Resistance to EGFR Kinase Inhibitors in Lung Cancer

W. Pao, N. Gray, D. Colvin, 2016 .

Eph receptor tyrosine kinases in cancer stem cells.

Wenqiang Song, Jin Chen, K. Amato, 2015, Cytokine & growth factor reviews.

Juliann Chmielecki with Evolutionary Cancer Modeling Small Cell Lung Cancer − Optimization of Dosing for EGFR-Mutant Non

N. Socci, A. Viale, M. Ladanyi, 2011 .

Combination chemotherapy in relapsed childhood acute lymphoblastic leukemia.

S. Sallan, J. Lipton, K. Amato, 1984, Cancer treatment reports.

Regulation of Endothelial Cell Proliferation and Vascular Assembly through Distinct mTORC2 Signaling Pathways

Dana M. Brantley-Sieders, Shan Wang, Wenqiang Song, 2015, Molecular and Cellular Biology.

Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC.

Dana M. Brantley-Sieders, N. Gray, D. Colvin, 2014, The Journal of clinical investigation.

Effects of cancer-associated EPHA3 mutations on lung cancer.

Yu Shyr, Mark Boothby, Yan Guo, 2012, Journal of the National Cancer Institute.

Eph receptor tyrosine kinases in cancer stem cells.

Wenqiang Song, Jin Chen, K. Amato, 2015, Cytokine & growth factor reviews.